Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
21.07.23
/
50%
€20.80
Target price
21.07.24
€25.14
Performance (%)
14.42%
End price
22.07.24
€23.80
Summary
This prediction ended on 22.07.24 with a price of €23.80. The prediction had a final performance of 14.42%. The_Goldman_Sachs_Gr has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -0.495% | -0.495% | -55.824% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,67 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 14,64 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,74 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 9,34 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $25.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten